RPL23AP69

Across TCGA pan-cancer cohorts, RPL23AP69 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPL23AP69 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPL23AP69 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL23AP69 expression acts as an unfavorable survival marker, although some lineages such as CHOL and BLCA show a favorable association.

STAD, OV, and UCEC are the cancer types where RPL23AP69 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	All	0.443	0.652	<.001	93	view →
OV	OS	Median	II,III,IV	0.274	0.371	.002	60	view →
UCEC	DFS	Tertile	IV	0.268	0.644	.009	38	view →
ACC	DFS	Tertile	All	0.207	0.545	.001	37	view →
COAD	DFS	Tertile	IV	0.272	0.567	.001	18	view →
PAAD	DFS	Tertile	II,III,IV	0.322	0.487	.012	15	view →
CHOL	OS	Tertile	All	1.000	0.498	.033	15	view →
SKCM	OS	Tertile	IV	0.232	0.777	.007	15	view →
LIHC	DFS	Tertile	III,IV	0.227	0.489	.024	15	view →
KIRC	OS	Tertile	All	0.824	0.911	.009	13	view →
BLCA	DFS	Median	II,III,IV	0.409	0.293	.029	7	view →
THYM	DFS	Quartile	All	1.000	0.667	.014	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPL23AP69–STAD (DFS)

Open the STAD breakdown →